139 related articles for article (PubMed ID: 12835478)
1. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.
Kelly JA; Spolski R; Kovanen PE; Suzuki T; Bollenbacher J; Pise-Masison CA; Radonovich MF; Lee S; Jenkins NA; Copeland NG; Morse HC; Leonard WJ
J Exp Med; 2003 Jul; 198(1):79-89. PubMed ID: 12835478
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas.
Abraham N; Ma MC; Snow JW; Miners MJ; Herndier BG; Goldsmith MA
Oncogene; 2005 Aug; 24(33):5252-7. PubMed ID: 15870688
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
Mitchell TJ; Whittaker SJ; John S
Cancer Res; 2003 Dec; 63(24):9048-54. PubMed ID: 14695224
[TBL] [Abstract][Full Text] [Related]
7. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
8. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
9. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
10. Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system.
Kazansky AV; Spencer DM; Greenberg NM
Cancer Res; 2003 Dec; 63(24):8757-62. PubMed ID: 14695191
[TBL] [Abstract][Full Text] [Related]
11. Coactivators in gene regulation by STAT5.
Litterst CM; Kliem S; Lodrini M; Pfitzner E
Vitam Horm; 2005; 70():359-86. PubMed ID: 15727811
[TBL] [Abstract][Full Text] [Related]
12. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
13. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
14. Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice.
Shang Y; Kakinuma S; Amasaki Y; Nishimura M; Kobayashi Y; Shimada Y
In Vivo; 2008; 22(6):713-20. PubMed ID: 19180996
[TBL] [Abstract][Full Text] [Related]
15. STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression.
Joo A; Aburatani H; Morii E; Iba H; Yoshimura A
Oncogene; 2004 Jan; 23(3):726-34. PubMed ID: 14737107
[TBL] [Abstract][Full Text] [Related]
16. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
Tamura T; Ariga H; Kinashi T; Uehara S; Kikuchi T; Nakada M; Tokunaga T; Xu W; Kariyone A; Saito T; Kitamura T; Maxwell G; Takaki S; Takatsu K
Int Immunol; 2004 Dec; 16(12):1691-9. PubMed ID: 15477229
[TBL] [Abstract][Full Text] [Related]
17. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.
Kato Y; Iwama A; Tadokoro Y; Shimoda K; Minoguchi M; Akira S; Tanaka M; Miyajima A; Kitamura T; Nakauchi H
J Exp Med; 2005 Jul; 202(1):169-79. PubMed ID: 15998795
[TBL] [Abstract][Full Text] [Related]
19. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells.
Yagi J; Arimura Y; Takatori H; Nakajima H; Iwamoto I; Uchiyama T
Int Immunol; 2006 Dec; 18(12):1681-90. PubMed ID: 17035345
[TBL] [Abstract][Full Text] [Related]
20. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]